ResearchNet - RechercheNet

Funding Organization
Canadian Institutes of Health Research
Program Name
Team Grant : Lung Health ARCHIVED
Sponsor(s)

Co-led by the Institute of Circulatory and Respiratory Health (ICRH) and the Institute of Cancer Research (ICR), in collaboration with the Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE), Institute of Gender and Health (IGH), the Institute of Genetics (IG), and the Institute of Infection and Immunity (III), and in partnership with the Canadian Cancer Society (CCS), the Canadian Lung Association (CLA), the Cancer Research Society (CRS), GlaxoSmithKline Inc. (GSK), the Heart and Stroke Foundation of Canada (H&S) and Mitacs (Updated: 2023-09-26)

Program Launch Date
2023-07-14
Deadline Date
TBD

Important Dates

Competition 202311LGH
CLOSED
Application Deadline 2023-11-16
Anticipated Notice of Decision 2024-03-28
Funding Start Date 2024-04-01

Notices

The content of this funding opportunity has been updated
Date updated: 2023-11-03
Section updated: Eligibility

On July 14, 2023, CIHR introduced the Manage Access task to allow a Nominated Principal Applicant (NPA) to delegate access to individuals on their team to support the completion of their application. Please see the How to Apply Instructions for further details.

CIHR will be hosting webinar(s) to support participants with the requirements of this funding opportunity and to answer questions. To find out more information and to register, visit the Webinars page.

CIHR is providing an Applicant Partner Linkage Tool that outlines in-kind partner contributions available to support the development of applications. It is not mandatory that applicants engage with partners providing in-kind contributions. Information is provided on a voluntary basis and use does not confer any advantages in the evaluation and funding of applications. The table will be updated weekly, until the application deadline. If your organization would like to be identified as a potential in-kind partner for applicants, please email ICRH.

This funding opportunity is part of a pilot project where applicants will be asked to provide a data management plan (DMP) when submitting their application. The objective of this pilot is to inform CIHR's implementation of the Tri-Agency Research Data Management Policy. DMPs are not part of the scoring nor the formal evaluation of your application. However, reviewers will be asked to comment on the appropriateness of your DMP to help inform the implementation of DMPs beyond the current pilot. CIHR might also reach out to applicants to understand their experience of developing DMPs. There is a separate requirement for applicants to the Data Science, Policy and Lung Health pool. See Cross-Cutting Themes and the How to Apply section for more details.

Table of Contents

Description


Background

All Canadians, across the lifecycle, are affected by the quality of the air we breathe, both indoors and outdoors. Inhalation of gases and toxins resulting from, but not limited to, smoking, vaping, radon and air pollution can significantly impact the health of the lungs and other organ systems, such as the heart and brain. Resultant absorption of particulate matter and aerosol pollutants can damage lung tissue directly and cause local and systemic inflammation throughout the body. Considering the ongoing, new and emerging threats to lung health, such as lung cancers among people who have never smoked, the effects of vaping on health, viral infections (e.g., SARS-CoV-2), and the impacts of climate change, there is an urgent need for strategic investment in lung health.

Across the lifecycle, particularly at the extremes of age (the very young and very old), individuals are vulnerable to the impact of poor air quality. Poor air quality (through air pollution, climate emergencies, and atmospheric inversions) has been linked to preventable emergency department (ED) visits, hospitalizations and even deaths. A diverse range of serious cardiovascular and respiratory conditions have been shown to increase within three days of increases in ozone, sulfur dioxide, nitrous oxide and carbon monoxide as measured through the Air Quality Health Index (AQHI). The pathophysiology of these resultant conditions is thought to be related to systemic inflammation, so it is perhaps not surprising that other inflammatory conditions such as stroke, heart attacks, infections, and headache can increase with poor air quality measures.

Moreover, cigarette smoking and vaping are estimated to contribute significantly to preventable deaths, hospitalizations and ED visits. The recent dramatic rise in vaping among youth who have never smoked, along with the E-cigarette and Vaping Products Acute Lung Injury (EVALI) crisis in the US and Canada prior to the pandemic, reflect the need to continue examining the health effects of vaping. While cigarette smoking has been linked to lung and multiple other cancers, lung cancers in people who haven't smoked are increasing, and the role of lung toxins in the etiology of these cancers requires additional investigation. Over time, the accumulated toxic load on the lung from ongoing exposure to environmental pollutants, such as smoking, vaping and poor air quality, becomes unsustainable and result in detrimental health effects on the lung. For individuals with underlying and/or active lung disease, these exposures result in increased symptom burden and morbidity.

Finally, there are inequitable impacts on lung health connected from geographical location, social status, ancestral heritage, sex, gender, sexual orientation and age. For example, it is becoming more common for people residing in remote, rural and northern communities to be adversely affected by poor air quality caused by wildfires. Women generally are both under-represented in research and mis-diagnosed for cardio-respiratory conditions, suggesting that sex and gender considerations are in urgent need of attention. Moreover, Indigenous Peoples (First Nations, Inuit and Métis) in Canada are at risk of greater exposure to toxins in their lungs due to higher smoking rates, crowded/poor housing and environmental factors that affect air and water quality. Interestingly, current evidence suggests there are wide differences between First Nations, Inuit and Métis populations related to rates of detection for various lung health conditions.

The goal of this funding opportunity is to unite interdisciplinary Research Teams to collectively address threats to lung health in a manner that leverages past investments, existing capacity, available infrastructure and research expertise.

Purpose

The purpose of the Team Grant funding opportunity is to fund interdisciplinary teams that will address ongoing, new and emerging threats to lung health by improving the understanding of biological, social, environmental and behavioural effects on lung health. Collectively, these teams will develop and disseminate evidence-based solutions for better lung health and overall wellness, including a focus on health disparities; equity, diversity and inclusion (EDI) analyses; and Indigenous contexts.

Team Structure and Application Requirements

This funding will support interdisciplinary Research Teams to address lung health within defined research areas. The Research Teams are expected to collaborate through identified cross-cutting themes to leverage expertise, experience and resources to collectively maximize the impact of the Research Teams on the lung health and overall wellness of people living in Canada (see Figure 1: Research Team Composition).

The Research Teams are to be interdisciplinary, address at least one of the identified Research Areas, contribute to the objectives of the funding opportunity, and collaborate and contribute to the identified cross-cutting themes (see below). Research Teams are expected to:

Cross-Cutting Themes: At a minimum, the following cross-cutting themes are required to be integrated within each Research Team. Each Research Team must designate an individual responsible for each cross-cutting theme (Theme Lead). Research Teams will be expected to collaborate on cross-cutting theme activities when funded. The additional considerations (section that follows) should also be incorporated into the cross-cutting themes and proposed research projects, as appropriate. Cross-cutting themes include:

Knowledge Mobilization (KM): Research Teams are expected to engage in KM activities committed to transforming existing and co-created new knowledge into better care policies, practices, procedures, products and services to promote lung health across Canada. The KM Plan should account for EDI considerations and be integrated throughout the research cycle, as appropriate, for the purpose of acquiring and mobilizing data and resources in human populations. Emphasis should be placed on priority-setting, co-production with stakeholders and people with lived or living experience, and knowledge synthesis to inform and implement high-quality evidence into policy and practice.

Data and Biosamples: Research Teams are expected to manage research data in accordance with international and disciplinary best practices. This applies to data collection, standardization, use, sharing, linkage, and, where appropriate, biosamples collected. Research Teams should also manage data in alignment with relevant Indigenous data governance principles, as appropriate, to reflect and respect Indigenous data governance and data sovereignty.

Due to the Data Science, Policy and Lung Health Research Team establishing and coordinating a data platform for the Data and Biosamples cross-cutting theme, applicants to the Data Science, Policy and Lung Health pool are required to submit a data governance plan that describes how these principles will be applied. The data governance plans will be included in evaluation of proposals (see Evaluation Criteria and How to Apply).

All other Research Team applicants are required to submit a data management plan that incorporates these principles. The data management plans will not be included in proposal evaluation (see Notices, How to Apply and Additional Information).

Once funded, all Research Teams are expected to collaborate with the Data Science, Policy and Lung Health Research Team in the development of a common data resource. The data and biosamples (as appropriate) which the Research Teams will bring to this national data resource should be outlined as a part of this cross-cutting theme in the research proposal.

Training and Capacity Development: Research Teams are required to develop recruitment, training (including experiential learning opportunities), and mentoring strategies to attract high-calibre trainees and ECRs from a diversity of population groups, including embedding and applying EDI practices, opportunities for cross-cultural learning to enhance capacity to address systemic racism in research, and developing capacity for meaningful and culturally safe engagement with Indigenous Peoples.

Additional Considerations

Research Areas

This funding opportunity will support projects relevant to the following research areas. Proposed Research Teams must be relevant to at least one research area but may also be relevant to multiple research areas.

Role and Contributions of Applicant Partners: CIHR recognizes that a broad range of partners may be relevant to this opportunity and it is expected that applicant(s) describe the role of all applicant partners and how/if they will contribute to research and research related activities. Any consideration of risk and/or conflict of interest should also be explained, as appropriate.

Funds Available

CIHR and partner(s) financial contributions for this initiative are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or are decreased due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to grants received as a result of this funding opportunity.

Additional Partner Funding

Mitacs funding is available to fund internships for participating trainees. Internship funding opportunities available through Mitacs include the Accelerate and Elevate programs. To learn more about these opportunities please contact Mitacs directly (see Contact Information). For more information on the appropriate use of funds, refer to Allowable Costs.


Top

Objectives


The specific objectives of this funding opportunity are to:


Top

Eligibility


Eligibility to Apply

For an application to be eligible, all the requirements stated below must be met:

  1. The Nominated Principal Applicant (NPA) must be an independent researcher affiliated with a Canadian postsecondary institution and/or its affiliated institutions (including hospitals, research institutes and other non-profit organizations with a mandate for health research and/or knowledge translation);
  2. The NPA must have their substantive role in Canada for the duration of the requested grant term.
  3. The Institution Paid must be authorized to administer CIHR funds by the application deadline (see List of CIHR Eligible Institutions ).
  4. The NPA must have successfully completed one of the sex-and gender-based analysis training modules available online through the CIHR Institute of Gender and Health and have submitted a Certificate of Completion (see How to Apply section).
  5. In addition to the NPA, a Research Team application must include multidisciplinary team members that demonstrate expertise to address each of the cross-cutting themes
  6. In addition to the NPA, at a minimum, each Research Team application must include the following:
    1. An Early career researcher(s) and/or mid-career researcher(s) as Principal Applicant(s); (Updated: 2023-11-03)
    2. Trainee(s);
    3. A Knowledge user(s); and
    4. Person(s) with lived/living experience: In the context of this funding opportunity, this includes individuals with personal experience of a health issue, and formal and informal caregivers, including family and friends.
  7. For Research Team applications undertaking Indigenous Health Research, at least one (1) team member must be:
    1. An independent researcher or knowledge user who self-identifies as Indigenous (First Nations, Inuit or Métis) and/or provides evidence of having meaningful and culturally safe involvement with Indigenous Peoples;
      OR
    2. An Indigenous Elder and/or an Indigenous Knowledge Keeper*;
      OR
    3. An Indigenous non-governmental organization;
      OR
    4. An individual associated with an Indigenous non-governmental organization.
  8. Applicants may be a NPA for one Research Team application only; however, an NPA may be involved as a co-applicant in other Research Team applications.

*A Knowledge Keeper (also known as a Knowledge Holder or Knowledge Guardian) is an Indigenous person, regardless of age, who possesses the Indigenous cultural knowledge necessary for the proposed research project or activities, as recognized, validated, and authenticated by the Indigenous community.


Top

Guidelines


General CIHR Policies

Before submitting an application to this funding opportunity, applicants should review the relevant policies and guidelines on the CIHR Funding Policies page to ensure understanding of their responsibilities and expectations.

Allowable Costs

Applicants are advised to consult the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Guide on Financial Administration (TAGFA) to determine if an expenditure is an appropriate use of grant funds.

To further clarify, the following expenses are examples of appropriate uses of grant funds, provided they satisfy the principles and pertinent directives of the TAGFA:

Use of Personal Information

Conditions of Funding

In addition:


Top

Review Process and Evaluation


Relevance Review Process

CIHR Institutes and applicable partner organizations involved in this funding opportunity will perform a relevance review to identify applications that are in alignment with the objectives and research areas of this funding opportunity.

Applications that are not deemed to be relevant will be withdrawn from the competition.

Review Process

Peer review will be conducted in accordance with the Review guidelines for priority-driven initiatives.

For information on CIHR's peer review principles, see the Peer Review: Overview section of CIHR's website.

Evaluation Criteria

To support the strategic objectives of this funding opportunity, the following evaluation criteria will be used:

  1. Research Approach
    1. The extent to which the research proposal is relevant to the objectives of the funding opportunity.
    2. Clarity and appropriateness of the research approach, proposed design, research methods and theories.
    3. Feasibility of the research approach (including recruitment of participants, project timeline[s], budget, preliminary data where appropriate, etc.) to address research questions.
    4. Extent to which the research proposal exhibits an interdisciplinary and multi-sectoral approach, and the strength of stakeholder and partner engagement, including the engagement and/or inclusion of people with lived/living experience, caregivers, Indigenous Peoples, racialized communities, government, policy makers, health care providers, researchers across the CIHR research pillars, and industry as appropriate.
    5. Appropriate consideration of enablers, as well as anticipated challenges and mitigation strategies, as appropriate, including those related to Indigenous community engagement, ethics, equity, communities facing vulnerabilities, racialized communities, management of patient engagement, and sex- and gender-based analysis.
    6. Evidence of previous or planned collaboration around data science, policy and resource sharing.
    7. Extent to which the research proposal integrates the cross-cutting themes and additional considerations.
    8. As appropriate, the extent to which the research proposal addresses Indigenous Health and wellness, including:
      1. Inclusion of research conducted by, grounded in, or engaged with First Nations, Inuit and/or Métis communities, societies or individuals and their wisdom, cultures, experiences or knowledge systems, as expressed in their dynamic forms, past and present as appropriate.
      2. Respect for Indigenous data governance, by applying the First Nations Principles of OCAP®1, and/or the CARE Principles2, or other principles of Indigenous data governance as appropriate.
      3. Appropriate consideration of TCPS 2 – Chapter 9: Research Involving the First Nations, Inuit and Métis Peoples of Canada, and meaningful and culturally safe practices, plans and activities throughout the research project.
  2. Originality of the Proposal
    1. Potential for the creation of new knowledge, technologies, and/or positive health system impacts.
    2. Originality of the proposed research, in terms of the hypotheses/research questions addressed, novel technology/methodology, and/or novel applications of current technology/methodology.
  3. Research Team and Applicants
    1. Evidence that the applicants have demonstrated leadership and required expertise in the field of lung health research.
    2. Evidence that the applicants have the necessary qualifications (including training, experience and independence, relative to career stage) in the proposed area of research and the proposed methodology.
    3. Evidence that the designated cross-cutting theme leads have appropriate experience and expertise in the identified theme area.
    4. Extent to which the leadership, membership and overall composition of the Research Team reflects EDI and a balance of diverse disciplines, sectors, CIHR pillars, and stakeholders, including knowledge users, people with lived/living experience, caregivers, Indigenous Peoples, early- and mid-career investigators, and trainees.
    5. As appropriate, the extent to which the Research Team has the necessary knowledge, expertise and experience in Indigenous health research, and complementarity of expertise and synergistic potential to conduct Indigenous health research.
    6. Appropriateness of the Research Team of applicants to carry out the proposed research, in terms of complementarity of expertise and synergistic potential and the capacity to overcome challenges.
    7. Potential to successfully disseminate research findings, as demonstrated by knowledge mobilization activities (publications, conference presentations, briefings, media engagements, etc.).
  4. Environment for the Research
    1. Suitability of the environment (including availability and accessibility of personnel, facilities and infrastructure) to conduct the research.
    2. Strength of the approach to optimize the utilization of resources, including the sharing of equipment, facilities and expertise.
    3. Extent to which the budget is appropriate and justified in relation to the proposed activities.
    4. Extent of the role(s) and contribution(s) of all applicant partner(s) in advancing research objectives (if applicable).
    5. Proactive and meaningful consideration of partnership risks, including the extent of real and/or perceived conflict of interest and appropriateness of its management and mitigation (if applicable).
  5. Impact of the Research
    1. Demonstration of the potential of the research plan to co-create new scientific knowledge that may contribute to achieving the objectives of this funding opportunity.
    2. Appropriateness and adequacy of the proposed knowledge mobilization plan, including engagement with people and communities affected by lung illnesses and factors that negatively affect lung health.

Additional Evaluation Criteria for Data Science, Policy and Lung Health Research Team:

  1. Comprehensiveness and quality of the data and biosample governance plan for supporting a data platform across the funded Research Teams. This includes:
    1. The extent to which the data and biosample governance plan describes how data and biosamples will be coordinated, stored, linked and shared across the Research Teams;
    2. The extent to which the plan describes how data and biosamples will be findable, accessible, interoperable and reusable (FAIR).
    3. The extent to which the plan identifies ethical considerations data and biosamples are subject to, and describes associated processes (e.g., data access procedures),
    It also includes, as appropriate:
    1. The extent to which activities are conducted by, grounded in, or engaged with First Nations, Inuit or Métis communities, societies or individuals and their wishidom, cultures, experiences or knowledge systems, as expressed in their dynamic forms, past and present.
    2. The extent to which the Research Team will address and respect Indigenous data governance, by applying the First Nations Principles of OCAP®1, the CARE Principles2, or other principles of Indigenous data governance as appropriate.
    3. Appropriate consideration of TCPS 2 – Chapter 9: Research Involving the First Nations, Inuit and Métis Peoples of Canada, and meaningful and culturally safe practices, plans and activities throughout the research project.
  2. Demonstrated evidence that the Applicant has the leadership, management abilities, and record of accomplishments to implement unified data governance and policies, including curation of biosamples (as appropriate), across Research Teams including collaborative sharing of interdisciplinary data under a common data governance structure.

Funding Decision

The top ranked Research Team application relevant to each Research Area will be funded.

The names of successfully funded applicants will be published on the CIHR website.

Partner and Internal Collaborator Participation

The opportunity to add new partners and internal collaborators to this funding opportunity may arise after publication. These partners and internal collaborators may not be listed; however, the principles that govern relevance review, including consent to share information and funding decisions, will still apply.


Top

How to Apply


Specific instructions to complete your ResearchNet application

Task: Identify Participants

Task: Enter Proposal Information

Task: Complete Summary of Research Proposal

Task: Enter Budget Information

Task: Attach Other Application Materials

Task: Identify Application Partners (optional) – Upload Partner Information

Task: Complete Peer Review Administration Information

Task: Apply to Priority Announcements/Funding Pools (Research Area)

Note: You must select no more than one primary Research Area as this will be used for Funding Decisions. If you select more than one Research Area in this task, only your first selection will be considered.

Task: Manage Access (optional)

  • The Nominated Principal Applicant (NPA) can delegate access to a maximum of five individuals to support the completion of the application. Note: A delegate's access does not carry over from one stage of the competition to another (i.e., from the registration to the application stage). The NPA will need to delegate access at each stage of a competition. NPAs should revoke delegates' access prior to completing the Consent and Submit tasks if they do not want them to retain access to submitted applications via their Completed Activities tab. For more information, please see the Frequently Asked Questions (FAQ).(Updated: 2023-07-14)

Task: Print/Upload Signature Pages


Top

Contact Information


For all inquiries, please contact:

CIHR Contact Centre
Telephone: 613-954-1968
Toll Free: 1-888-603-4178
Email: support-soutien@cihr-irsc.gc.ca

For service hours, please consult our Contact us page.

For all inquiries related to Mitacs, please contact:

Simon Bousquet
Senior Director, Business Development Operations, Mitacs
Telephone: 819-571-2936
Email: sbousquet@mitacs.ca


Top

Sponsor Description


Note: Additional partners/collaborators, including partners/collaborators from industry and the private sector may join this funding initiative over the coming year.

Partners

Canadian Cancer Society (CCS)
The Canadian Cancer Society is a national charity that funds ground-breaking research, provides trusted information about cancer, offers programs and services to help people with cancer and their families cope, and advocates to governments for important social change to make healthy living easier. CCS has created the Centre for Cancer Prevention and Support (CCPS) to accelerate the progress of research into action, particularly in the areas of cancer prevention and survivorship. Through CCPS, CCS will play a more active role in facilitating knowledge translation and evidence dissemination for the research we fund.

Canadian Lung Association (CLA)
The mission of the Canadian Lung Association is to lead nationwide and international lung health initiatives, prevent lung disease, help people manage lung disease and promote lung health. The vision is "all people free of lung disease" and a desire to see a future where this is possible.

Cancer Research Society (CRS)
The Cancer Research Society is a pan-Canadian not-for-profit organization whose sole mission is to fund research on all types of cancer to help prevent, detect, and treat this disease.

GSK
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies. We aim to positively impact the health of 2.5 billion people over the next 10 years.

(Updated: 2023-09-26)

Heart & Stroke
Life. We don't want you to miss it. That's why Heart & Stroke leads the fight against heart disease and stroke. We must generate the next medical breakthroughs so people in Canada don't miss out on precious moments. Together, we are working to promote health, save lives and enhance recovery through research, health promotion and public policy.

Mitacs
Mitacs is a national, not-for-profit (NFP) organization that designs and delivers research and training programs with demonstrable economic or productivity orientation in Canada. In partnership with companies, eligible not-for-profit organizations, government and academia, Mitacs is developing the next generation of innovators with vital scientific and business skills.

Internal Collaborators

Canadian Institutes of Health Research
At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.

CIHR – Institute of Circulatory and Respiratory Health (ICRH)
The Institute of Circulatory and Respiratory Health (ICRH) supports research into the causes, mechanisms, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep. The ICRH vision is to achieve international leadership by fostering an environment of openness, excitement, energy, commitment and excellence in highly ethical, partnered initiatives focused on research, research training, and research translation for the circulatory and respiratory sciences and for the betterment of the health of Canadians.

CIHR – Institute of Cancer Research (ICR)
The CIHR Institute of Cancer Research (ICR) funds cancer research in Canada based on internationally accepted standards of excellence, which bear on preventing and treating cancer, and improving the health and quality of life of cancer patients. ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

CIHR – Institute of Gender and Health (IGH)
The CIHR Institute of Gender and Health (IGH) invests in research that examines the influence of sex and gender on health. IGH also works to ensure this research evidence supports the development of policies and programs that address pressing health challenges facing men, women, boys, girls, and gender-diverse people.

CIHR – Institute of Genetics (IG)
The CIHR Institute of Genetics (IG) invests in research on cell biology, biochemistry, human genetics and genomics, and the impact of related scientific advances on society. Genetic research touches all areas of health, allowing IG to strengthen health care policies and practices, and improve the health of all Canadians.

CIHR – Institute of Infection and Immunity (III)
The CIHR Institute of Infection and Immunity (III) invests in research on infectious diseases and the body's immune system. Through this research, III addresses a wide range of health concerns related to infection and immunity, including disease prevention and treatment, as well as public health promotion.

Centre for Research on Pandemic Preparedness and Health Emergencies
The Research Centre, which is housed within CIHR, will ensure Canada has an emergency-ready health research system. The Research Centre builds on Canada's research strengths and continues to grow its capacity to be a leader in preventing, preparing for, responding to, and recovering from existing and future pandemics and public health emergencies. It collaborates with other federal departments and agencies, as well as stakeholders domestically and internationally.


Top

Additional Information


Data Management Plans

A data management plan (DMP) is a formal document that details the strategies and tools you will implement to effectively manage your data both during your research project and after its completion. DMPs contribute to:

For more information on research data management and DMPs, visit the Frequently Asked Questions of the Tri-Agency Research Data Management Policy, and the Training Resources page of the Digital Research Alliance of Canada.

DMP Assistant is a national, online, bilingual data management planning tool developed by the Digital Research Alliance of Canada in collaboration with host institution University of Alberta to assist researchers in preparing DMPs. This tool is freely available to all researchers, and develops a DMP through a series of key data management questions, supported by best-practice guidance and examples.

If using DMP Assistant to create their DMPs, when asked to choose a template applicants should select "Portage Template" or, if applicable, their institution's customized version of the Portage Template. There is no prescribed length for DMPs – however, applicants are encouraged to keep them succinct and focused, ideally within two pages if possible. Questions about using DMP Assistant should be directed to the DMP Assistant support.

Should you have any questions or concerns about this pilot activity, please contact our Research Data Management team.

Consent for human genomics research

For more guidance on obtaining consent for human genome studies, please refer to recently published article in the Canadian Medical Association Journal "Core elements of participant consent documents for Canadian human genomics research and the National Human Genome Library: guidance for policy".

References

  1. OCAP®, is a registered trademark of the First Nations Information Governance Centre.
  2. S. R. Carroll, I. Garba, O. L. Figueroa-Rodríguez, J. Holbrook, R. Lovett, S. Materechera and M. Hudson, "The CARE Principles for Indigenous Data Governance," Data Science, pp. 19(1), 43. , 2020.

Top

Date Modified: